Open access · CC-BY
via OpenAlex
RECONSIDERING REPURPOSING: LONG-TERM METFORMIN TREATMENT IMPAIRS COGNITION IN ALZHEIMER’S MODEL MICE
So Yeon Cho, Soo Jin Park, Benjamin U. Phillips, Jihyeon Jeong, Hyunjeong Kim, Christopher J. Heath, Daehwan Kim, Yurim Jang, Laura López‐Cruz, Lisa M. Saksida, Timothy J. Bussey, Do Yup Lee, Eosu Kim
Translational Psychiatry · 2023 · ▲ 56 citations
Abstract
Abstract Metformin, a primary anti-diabetic medication, has been anticipated to provide benefits for Alzheimer’s disease (AD), also known as “type 3 diabetes”. Nevertheless, some studies have demonstrated that metformin may trigger AD pathology and even elevate AD risk in humans. Despite this, limited research has elucidated the behavioral outcomes of metformin treatment, which would hold significant translational value. Thus, we aimed to perform thorough behavioral research on the prolonged administration of metformin to mice: We administered metformin (300 mg/kg/day) to transgenic 3xTg-AD and non-transgenic (NT) C57BL/6 mice over 1 and 2 years, respectively, and evaluated their behaviors across multiple domains via touchscreen operant chambers, including motivation, attention, memory, visual discrimination, and cognitive flexibility. We found metformin enhanced attention, inhibitory control, and associative learning in younger NT mice (≤16 months). However, chronic treatment led to impairments in memory retention and discrimination learning at older age. Furthermore, metformin caused learning and memory impairment and increased levels of AMPKα1-subunit, β-amyloid oligomers, plaques, phosphorylated tau, and GSK3β expression in AD mice. No changes in potential confounding factors on cognition, including levels of motivation, locomotion, appetite, body weight, blood glucose, and serum vitamin B12, were observed in metformin-treated AD mice. We also identified an enhanced amyloidogenic pathway in db/db mice, as well as in Neuro2a-APP 695 cells and a decrease in synaptic markers, such as PSD-95 and synaptophysin in primary neurons, upon metformin treatment. Our findings collectively suggest that the repurposing of metformin should be carefully reconsidered when this drug is used for individuals with AD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/s41398-024-02755-9
- Canonical
- link ↗
- Fetched
- 2026-11-09 MST
Cite this
APA
Cho, S.Y., Park, S.J., Phillips, B.U., Jeong, J., Kim, H., Heath, C.J., Kim, D., Jang, Y., López‐Cruz, L., Saksida, L.M., Bussey, T.J., Lee, D.Y., & Kim, E. (2023). RECONSIDERING REPURPOSING: LONG-TERM METFORMIN TREATMENT IMPAIRS COGNITION IN ALZHEIMER’S MODEL MICE. <em>Translational Psychiatry</em>. https://doi.org/10.1038/s41398-024-02755-9
Vancouver
Cho SY, Park SJ, Phillips BU, Jeong J, Kim H, Heath CJ, et al. RECONSIDERING REPURPOSING: LONG-TERM METFORMIN TREATMENT IMPAIRS COGNITION IN ALZHEIMER’S MODEL MICE. Translational Psychiatry. 2023. doi:10.1038/s41398-024-02755-9.
BibTeX
@article{so2023RECONS,
title = {RECONSIDERING REPURPOSING: LONG-TERM METFORMIN TREATMENT IMPAIRS COGNITION IN ALZHEIMER’S MODEL MICE},
author = {So Yeon Cho and Soo Jin Park and Benjamin U. Phillips and Jihyeon Jeong and Hyunjeong Kim and Christopher J. Heath and Daehwan Kim and Yurim Jang and Laura López‐Cruz and Lisa M. Saksida and Timothy J. Bussey and Do Yup Lee and Eosu Kim},
journal = {Translational Psychiatry},
year = {2023},
doi = {10.1038/s41398-024-02755-9},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Translational Psychiatry 2024
Open access · CC-BY
Reconsidering repurposing: long-term metformin treatment impairs cognition in Alzheimer’s model mice
Cell Reports 2014
Open access · CC-BY
Life Extension Factor Klotho Enhances Cognition
Current Alzheimer Research 2015
Preprint · OA
Age-Dependent Biochemical Dysfunction in Skeletal Muscle of Triple- Transgenic Mouse Model of Alzheimer&#96;s Disease
Frontiers in Aging Neuroscience 2025
Open access · CC-BY
Metformin improves age-related visual cortex dysfunction in mice by reducing noise correlation in the primary visual cortex
Aging Cell 2014
Open access · CC-BY
Relative importance of redox buffers GSH and NAD (P)H in age‐related neurodegeneration and Alzheimer disease‐like mouse neurons
Aging 2016
Open access · CC-BY